Haemonetics HAE Plasma — D&A

Similar metrics at other companies

OTT

OTTRPlastics — D&A

$1.67M+8.2%

CPBMeals & Beverages — D&A

$40M-4.8%

HXLEngineered Products — D&A

$3.2M0.0%

CCAdvanced Performance Materials — D&A

$23M-34.3%

HLIOElectronics — D&A

$2.2M-4.3%

SXIElectronics Products Group — D&A

$5.08M-10.7%

Questions, answered.

What is Haemonetics's plasma — D&A?

Haemonetics (HAE) reported plasma — D&A of $11.84M in Q1 2026.

How has Haemonetics's plasma — D&A changed year-over-year?

Haemonetics's plasma — D&A decreased by 1.9% year-over-year, from $12.07M to $11.84M.

What is the long-term trend for Haemonetics's plasma — D&A?

Over 2 years (2024 to 2026), Haemonetics's plasma — D&A has grown at a 1.8% compound annual growth rate (CAGR), from $45.71M to $47.37M.

What does plasma — D&A mean?

Reflects the non-cash allocation of the cost of tangible and intangible assets specifically attributed to the plasma segment over their useful lives. This metric is essential for understanding the capital intensity of the segment and for calculating EBITDA. It helps investors gauge the level of reinvestment required to maintain the segment's operational infrastructure.